Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.92 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acesulfame SCHEMBL4104 | 0.98 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL7568032 | 0.98 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL17766790 | 0.98 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL3126570 | 0.98 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL7594675 | 0.96 | CA9 (1.00) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL3551 | 0.96 | CA9 (1.00) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL328775 | 0.94 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL17350249 | 0.94 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL328789 | 0.94 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL38654964 | 0.94 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2007384-A1 | ORODISPERSIBLE DOMPERIDONE TABLETS | Pierre Fabre Medicament (FR) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007104771-A1 | ORODISPERSIBLE DOMPERIDONE TABLETS | PIERRE FABRE MEDICAMENT (FR) | 2007-09-20 | — | — | WO | disclosed |